Articles

Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial

Fondazione IRCCS Policlinico San Matteo Pavia;
Fondazione IRCCS Policlinico S. Matteo; University of Pavia;
Fondazione IRCCS Policlinico San Matteo Pavia; University of Pavia;
Fondazione IRCCS Policlinico San Matteo Pavia;
Fondazione IRCCS Policlinico San Matteo Pavia;
Carlo Poma Hospital, ASST Mantova;
Fondazione IRCCS Policlinico San Matteo Pavia;
Carlo Poma Hospital, ASST Mantova;
Fondazione IRCCS Policlinico San Matteo Pavia;
Fondazione IRCCS Policlinico San Matteo Pavia;
Carlo Poma Hospital, ASST Mantova;
Fondazione IRCCS Policlinico San Matteo Pavia; university of Pavia;
Carlo Poma Hospital, ASST Mantova;
Fondazione IRCCS Policlinico San Matteo Pavia, University of Pavia;
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Carlo Poma Hospital, ASST Mantova;
Carlo Poma Hospital, ASST Mantova;
Haematologica Early view Jul 23, 2020 https://doi.org/10.3324/haematol.2020.261784